Krystal Biotech (KRYS) Raw Materials (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Raw Materials data on file, last reported at $15.2 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials changed 0.22% year-over-year to $15.2 million; the trailing twelve-month figure through Mar 2026 stood at $15.2 million (changed 0.22% YoY), and the FY2025 full-year result was $15.9 million, up 16.86% from the prior year.
• Raw Materials retreated to $15.2 million in Q1 2026, from $15.9 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $15.9 million in Q4 2025 to a low of $3.2 million in Q4 2023.
• A 4-year average of $11.1 million and a median of $13.8 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials jumped 332.44% in 2024 and gained 0.22% in 2026, its largest moves.
• Tracing KRYS's Raw Materials over 4 years: stood at $3.2 million in 2023, then jumped by 332.44% to $13.6 million in 2024, then increased by 16.86% to $15.9 million in 2025, then dropped by 4.8% to $15.2 million in 2026.
• Business Quant data shows KRYS's Raw Materials at $15.2 million in Q1 2026, $15.9 million in Q4 2025, and $14.6 million in Q3 2025.